IMG-20251212-WA0011 - Doctor Dyar

Modern Evidence-Based Approaches for the Management of Persistent and Recurrent Vaginitis

Laboratorio Elea, a leading Argentine pharmaceutical company, successfully organized an educational scientific meeting for gynecologists in Mosul, held at the White Tower Hotel. The event focused on “Modern Evidence-Based Approaches for the Management of Persistent and Recurrent Vaginitis,” addressing one of the most challenging and frequently encountered conditions in gynecological practice.

The session provided an in-depth review of the latest international and CDC recommendations, with particular emphasis on long-term maintenance therapy for recurrent cases. Experts highlighted the clinical importance of twice-weekly vaginal suppository regimens administered over a period of 3 to 6 months to reduce recurrence rates and improve patient quality of life.

The discussion also reinforced the continued role of metronidazole as a first-line therapeutic option, noting its proven efficacy in controlling infection while preserving the normal vaginal microbiota, especially Lactobacillus species. Through evidence-based insights and practical clinical guidance, the event aimed to support physicians in optimizing treatment strategies and achieving better outcomes for patients suffering from recurrent vaginal infections.

  • Date: December 11, 2025
  • Time: 08:00 PM
  • Venue: White Tower Hotel
  • Location: Mosul, Iraq
  • Address: Near Super Qi Banking Service
photo_2025-12-13_22-25-08

XenoFarma Participates in World Diabetes Day Event in Kirkuk — Introducing Innofer 10 and 20 to Pediatric Specialists

XenoFarma (Emergopharm) marketing and sales team proudly participated in the World Diabetes Day event held at Azadi Teaching Hospital in Kirkuk. The meeting brought together pediatric specialists to discuss key challenges associated with diabetes management in children.

During the event, our team delivered an informative session on anemia in patients with diabetes, highlighting its impact on overall health and quality of life. We also introduced Innofer 10 & 20, emphasizing their clinical relevance, efficacy, and role in managing iron deficiency among patients with chronic conditions.

This engagement reflects XenoFarma’s commitment to supporting healthcare professionals with high-quality products and evidence-based medical education. We thank the pediatric specialists in Kirkuk for their participation and valuable discussions.

Date: January 12, 2025 – 9:00 AM
Location: Azadi Teaching Hospital, Kirkuk
Venue: Main Meeting Room